S025 Dermatologic Surgery Pearls: Optimizing Safety, Satisfaction, Efficiency
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
This session will recognize opportunities to enhance the overall dermatologic surgery practice by highlighting pearls to improve patient safety and satisfaction. Discussions will also focus on physician safety and tips on optimizing efficiency in the surgical setting.
LEARNING OBJECTIVES
Discuss pearls to optimize patient and physician safety while maximizing efficiency in the dermatologic surgery clinical practice.
Discuss strategies to improve patient experience and satisfaction.
SCHEDULE
2:00 PM
Nail Surgery Tips
Kimberly Marie Ken, MD, FAAD
2:16 PM
Managing Complications
Ramin Fathi, MD, FAAD
2:32 PM
Skin Cancer Diagnostic Conundrums
Valencia D. Thomas, MD, FAAD
2:48 PM
Q&A
3:00 PM
Photography/Biopsy site identification
Kishwer S. Nehal, MD, FAAD
3:16 PM
Technology tools
David R. Carr, MD, MPH, FAAD
3:32 PM
Surgical Revision Pearls
Teo Soleymani, MD
3:48 PM
Q&A
4:00 PM
Improving Wellness and Health
Emily Clara Newsom, MD, FAAD
4:16 PM
Reducing risk of surgical injuries
Rachel Rigo, MD, FAAD
4:32 PM
Ergonomics in your practice
Patrick K. Lee, MD, FAAD
4:48 PM
Q&A
SPEAKERS
David R. Carr, MD, MPH, FAAD
Ramin Fathi, MD, FAAD
Kimberly Marie Ken, MD, FAAD
Patrick K. Lee, MD, FAAD
Kishwer S. Nehal, MD, FAAD
Emily Clara Newsom, MD, FAAD
Rachel Rigo, MD, FAAD
Teo Soleymani, MD
Valencia D. Thomas, MD, FAAD
SPEAKER DISCLOSURES
David R. Carr, MD, MPH, FAAD
Regeneron – Investigator(No Compensation Received);
Ramin Fathi, MD, FAAD
No financial relationships exist with ineligible companies.
Kimberly Marie Ken, MD, FAAD
No financial relationships exist with ineligible companies.
Patrick K. Lee, MD, FAAD
No financial relationships exist with ineligible companies.
Kishwer S. Nehal, MD, FAAD
No financial relationships exist with ineligible companies.
Emily Clara Newsom, MD, FAAD
No financial relationships exist with ineligible companies.
Rachel Rigo, MD, FAAD
No financial relationships exist with ineligible companies.
Teo Soleymani, MD
No financial relationships exist with ineligible companies.
Valencia D. Thomas, MD, FAAD
Castle Biosciences, Inc – Advisory Board(Honoraria); Merk – Advisory Board(Honoraria); National Comprehensive Cancer Network – Speaker(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria);